Fox Business Flash top headlines for October 12
Fox Business Flash top headlines are here. Check out what’s clicking on FoxBusiness.com.
Securities and Exchange Commission filings show that two executives at Regeneron, a biotech company at the cutting edge of coronavirus treatment, netted about $1 million through sales of the company's stock after President Trump praised what he described as Regeneron's coronavirus "cure," although the company told NBC News the sales occurred as part of "pre-established" plans.
Continue Reading Below
|REGN||REGENERON PHARMACEUTICALS INC.||600.17||-1.90||-0.32%|
SEC filings and Regeneron's website show that board member Joseph L. Goldstein and Marion McCourt, senior vice president and head of commercial, made approximately $740,000 and $260,000, respectively, after selling shares on Oct. 5.
REGENERON CEO SAYS PRESIDENT TRUMP'S ANTIBODY COCKTAIL TREATMENT IS 'CASE REPORT'
President Trump has praised the antibody treatments from Regeneron and Eli Lilly that he says helped him following his coronavirus diagnosis.
"If you look at the therapeutics, which I'm taking right now, some of them and others are coming out soon that are looking like, frankly, they're miracles, if you want to know the truth. They're miracles … coming down from God," Trump said in an Oct. 3 video. "I'm starting to feel good."